Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - OMNI BIO PHARMACEUTICAL, INC. | c02831exv32w2.htm |
10-K - EXHIBIT 10-K - OMNI BIO PHARMACEUTICAL, INC. | c02831e10vk.htm |
EX-21 - EXHIBIT 21 - OMNI BIO PHARMACEUTICAL, INC. | c02831exv21.htm |
EX-14.1 - EXHIBIT 14.1 - OMNI BIO PHARMACEUTICAL, INC. | c02831exv14w1.htm |
EX-31.1 - EXHIBIT 31.1 - OMNI BIO PHARMACEUTICAL, INC. | c02831exv31w1.htm |
EX-31.2 - EXHIBIT 31.2 - OMNI BIO PHARMACEUTICAL, INC. | c02831exv31w2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Omni Bio Pharmaceutical, Inc. (the Company) on Form 10-K
for the fiscal year ended March 31, 2010 (the Report), I, Charles A. Dinarello, Acting Chief
Executive Officer of the Company, hereby certify that, to the best of my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company for the period covered by this report.
Date: June 25, 2010 | /s/ Charles A. Dinarello | |||
Charles A. Dinarello | ||||
Acting Chief Executive Officer |